Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the American College of Radiology and the American Academy of Allergy, Asthma & Immunology.
IF 12.1
1区 医学
Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Carolyn Wang,Allison Ramsey,David Lang,Ana Maria Copaescu,Pranay Krishnan,Merin Kuruvilla,Benjamin Mervak,Jeffrey Newhouse,Alisa Sumkin,Rebecca Saff
求助PDF
{"title":"Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the American College of Radiology and the American Academy of Allergy, Asthma & Immunology.","authors":"Carolyn Wang,Allison Ramsey,David Lang,Ana Maria Copaescu,Pranay Krishnan,Merin Kuruvilla,Benjamin Mervak,Jeffrey Newhouse,Alisa Sumkin,Rebecca Saff","doi":"10.1148/radiol.240100","DOIUrl":null,"url":null,"abstract":"Intravenous iodinated contrast media (ICM) is widely used in the United States, and it is imperative to provide guidance on the management of adverse reactions to ICM as well as the preparation, planning, and potential premedication for patients with previous reactions. Currently there is a discordance between the American College of Radiology Contrast Manual, which recommends premedication to prevent repeat hypersensitivity reactions to ICM, and the Anaphylaxis 2020 Practice Parameters Update, which recommends against routine administration of glucocorticoids and/or antihistamines to prevent anaphylaxis with prior ICM hypersensitivity reactions. A task force of experts from radiology who are also members of the American College of Radiology Committee on Drugs and Contrast Media and expert allergists/immunologists including members of the Adverse Reactions to Drugs, Biologics and Latex Committee of American Academy of Allergy, Asthma & Immunology evaluated the scientific evidence to develop consensus recommendations that are endorsed by both organizations. The task force took into account the strength of evidence and balanced the potential risks of recurrent reactions with those of premedication and product avoidance when making these recommendations to improve and standardize the care of patients who experience or have a history of reaction to ICM. © Radiological Society of North America and American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology and by Radiological Society of North America. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This paper was jointly developed by The Journal of Allergy and Clinical Immunology: In Practice, Radiology and jointly published by Elsevier Inc and Radiological Society of North America. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. Keywords: Contrast allergy, Contrast hypersensitivity, Iodinated contrast allergy, Iodinated contrast hypersensitivity, Anaphylaxis, Contrast skin testing, Contrast switching, Contrast reaction, Delayed contrast reaction, Immediate contrast reaction.","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"24 1","pages":"e240100"},"PeriodicalIF":12.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.240100","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Intravenous iodinated contrast media (ICM) is widely used in the United States, and it is imperative to provide guidance on the management of adverse reactions to ICM as well as the preparation, planning, and potential premedication for patients with previous reactions. Currently there is a discordance between the American College of Radiology Contrast Manual, which recommends premedication to prevent repeat hypersensitivity reactions to ICM, and the Anaphylaxis 2020 Practice Parameters Update, which recommends against routine administration of glucocorticoids and/or antihistamines to prevent anaphylaxis with prior ICM hypersensitivity reactions. A task force of experts from radiology who are also members of the American College of Radiology Committee on Drugs and Contrast Media and expert allergists/immunologists including members of the Adverse Reactions to Drugs, Biologics and Latex Committee of American Academy of Allergy, Asthma & Immunology evaluated the scientific evidence to develop consensus recommendations that are endorsed by both organizations. The task force took into account the strength of evidence and balanced the potential risks of recurrent reactions with those of premedication and product avoidance when making these recommendations to improve and standardize the care of patients who experience or have a history of reaction to ICM. © Radiological Society of North America and American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology and by Radiological Society of North America. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This paper was jointly developed by The Journal of Allergy and Clinical Immunology: In Practice, Radiology and jointly published by Elsevier Inc and Radiological Society of North America. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. Keywords: Contrast allergy, Contrast hypersensitivity, Iodinated contrast allergy, Iodinated contrast hypersensitivity, Anaphylaxis, Contrast skin testing, Contrast switching, Contrast reaction, Delayed contrast reaction, Immediate contrast reaction.
管理和预防对造影剂的超敏反应:美国放射学会和美国过敏、哮喘和免疫学学会的共识声明。
静脉碘化造影剂(ICM)在美国被广泛使用,对ICM不良反应的管理以及有不良反应的患者的准备、计划和可能的预用药提供指导是非常必要的。目前,美国放射学会对比手册和过敏反应2020实践参数更新之间存在不一致,前者建议预先用药以防止ICM的重复超敏反应,后者建议不常规使用糖皮质激素和/或抗组胺药来预防已有ICM超敏反应的过敏反应。一个由放射学专家组成的工作组,他们也是美国放射学会药物和造影剂委员会的成员,以及过敏症专家/免疫学专家,包括美国过敏、哮喘和免疫学学会药物、生物制品和乳胶不良反应委员会的成员,对科学证据进行了评估,以制定得到两个组织认可的共识建议。在提出这些建议以改善和规范对有ICM反应史或有ICM反应史的患者的护理时,工作组考虑了证据的强度,并平衡了复发反应的潜在风险与用药前和产品避免的潜在风险。©北美放射学会和美国过敏、哮喘和免疫学学会。由爱思唯尔公司代表美国过敏、哮喘和免疫学学会和北美放射学会出版。版权所有,包括文本和数据挖掘、人工智能训练及类似技术。本文由The Journal of Allergy and Clinical Immunology: In Practice, Radiology联合开发,Elsevier Inc .和Radiological Society of North America联合出版。这些文章都是一样的,除了风格和拼写上的小差异,以保持每个期刊的风格。在引用本文时,可以使用任何一种引用。关键词:造影剂过敏,造影剂超敏反应,碘化造影剂过敏,碘化造影剂超敏反应,过敏反应,造影剂皮肤试验,造影剂切换,造影剂反应,延迟造影剂反应,即时造影剂反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。